Search Results - "Leval, Xavier de"

Refine Results
  1. 1

    Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2 by BENOIT, Valérie, RELIC, Biserka, DE LEVAL, Xavier, CHARIOT, Alain, MERVILLE, Marie-Paule, BOURS, Vincent

    Published in Oncogene (26-02-2004)
    “…The oncoprotein HER-2/neu is a prosurvival factor and its overexpression has been correlated with adverse prognosis in breast cancers. High levels of the…”
    Get full text
    Journal Article Web Resource
  2. 2

    Therapeutic potential of thromboxane inhibitors in asthma by Dogné, Jean-Michel, de Leval, Xavier, Benoit, Patricia, Rolin, Stephanie, Pirotte, Bernard, Masereel, Bernard

    Published in Expert opinion on investigational drugs (01-02-2002)
    “…This paper reviews the role of thromboxane A(2) (TXA(2)) in the pathogenesis of pulmonary allergies, particularly asthma. The potential of TXA(2) modifiers in…”
    Get more information
    Journal Article
  3. 3

    New trends in dual 5-LOX/COX inhibition by Leval, Xavier de, Julemont, Fabien, Delarge, Jacques, Pirotte, Bernard, Dogne, Jean-Michel

    Published in Current medicinal chemistry (01-05-2002)
    “…Dual inhibitors are drugs able to block both the COX and the 5-LOX metabolic pathways. The interest of developing such compounds is supported by a large number…”
    Get more information
    Journal Article
  4. 4

    Evaluation of original dual thromboxane A2 modulators as antiangiogenic agents by de Leval, Xavier, Dassesse, Thibaut, Dogné, Jean-Michel, Waltregny, David, Bellahcène, Akeila, Benoit, Valérie, Pirotte, Bernard, Castronovo, Vincent

    “…Angiogenesis is a promising target for the therapy of several diseases including cancer. This study was undertaken to characterize the antiangiogenic…”
    Get more information
    Journal Article
  5. 5

    Recent advances in inducible cyclooxygenase (COX-2) inhibition by de Leval, X, Delarge, J, Somers, F, de Tullio, P, Henrotin, Y, Pirotte, B, Dogné, J M

    Published in Current medicinal chemistry (01-10-2000)
    “…Cyclooxygenase is the key enzyme in the biosynthesis of prostanoids, biologically active substances that are involved in several physiological processes but…”
    Get more information
    Journal Article
  6. 6

    New trends in thromboxane and prostacyclin modulators by Dogné, J M, de Leval, X, Delarge, J, David, J L, Masereel, B

    Published in Current medicinal chemistry (01-06-2000)
    “…Thromboxane A2 (TXA2) and prostacyclin (PGI2) are two labile products formed from arachidonic acid by the way of cyclooxygenase. An overproduction of…”
    Get more information
    Journal Article
  7. 7
  8. 8

    N-(3-Arylaminopyridin-4-yl)alkanesulfonamides as pyridine analogs of nimesulide: Cyclooxygenases inhibition, anti-inflammatory studies and insight on metabolism by Renard, Jean-François, Lecomte, Frédéric, Hubert, Philippe, de Leval, Xavier, Pirotte, Bernard

    Published in European journal of medicinal chemistry (03-03-2014)
    “…Nimesulide, a COX-2 preferential inhibitor with a favorable gastric and cardiovascular safety profile, was responsible for some cases of acute liver failure…”
    Get full text
    Journal Article Web Resource
  9. 9

    Pyridine Analogues of Nimesulide: Design, Synthesis, and in Vitro and in Vivo Pharmacological Evaluation as Promising Cyclooxygenase 1 and 2 Inhibitors by Renard, Jean-François, Arslan, Deniz, Garbacki, Nancy, Pirotte, Bernard, de Leval, Xavier

    Published in Journal of medicinal chemistry (08-10-2009)
    “…Nonsteroidal anti-inflammatory drugs (NSAIDs) represent one of the most prescribed medications, although the chronic use of such pharmacological agents is…”
    Get full text
    Journal Article Web Resource
  10. 10

    Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage by Dassesse, Thibaut, de Leval, Xavier, de Leval, Laurence, Pirotte, Bernard, Castronovo, Vincent, Waltregny, David

    Published in European urology (01-11-2006)
    “…We investigated the potential involvement of the thromboxane A(2) (TXA(2)) pathway in human prostate cancer (PCa). Expression of cyclooxygenase-2 (COX-2),…”
    Get full text
    Journal Article Web Resource
  11. 11

    Structure-based pharmacophore of COX-2 selective inhibitors and identification of original lead compounds from 3D database searching method by Michaux, Catherine, de Leval, Xavier, Julémont, Fabien, Dogné, Jean-Michel, Pirotte, Bernard, Durant, François

    Published in European journal of medicinal chemistry (01-12-2006)
    “…A four-point pharmacophore of COX-2 selective inhibitors was derived from a training set of 16 compounds, using the Catalyst program. It consists of a H bond…”
    Get full text
    Journal Article Web Resource
  12. 12

    New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulators by de Leval, Xavier, Hanson, Julien, David, Jean-Louis, Masereel, Bernard, Pirotte, Bernard, Dogné, Jean-Michel

    Published in Current medicinal chemistry (01-05-2004)
    “…Prostacyclin (PGI(2)) is a potent endogenous inhibitor of platelet function and possesses a strong vasodilator effect. Furthermore, prostacyclin is currently…”
    Get more information
    Journal Article
  13. 13

    Increased Expression of Bone Sialoprotein in Bone Metastases Compared with Visceral Metastases in Human Breast and Prostate Cancers by Waltregny, David, Bellahcène, Akeila, De Leval, Xavier, Florkin, Benoǐt, Weidle, Ulrich, Castronovo, Vincent

    Published in Journal of bone and mineral research (01-05-2000)
    “…The recent demonstration that bone sialoprotein (BSP) is expressed in osteotropic cancers suggests that this bone matrix protein might be implicated in the…”
    Get full text
    Journal Article Web Resource
  14. 14

    New developments on thromboxane and prostacyclin modulators part I: thromboxane modulators by Dogné, Jean-Michel, de Leval, Xavier, Hanson, Julien, Frederich, Michel, Lambermont, Bernard, Ghuysen, Alexandre, Casini, Angela, Masereel, Bernard, Ruan, Ke-He, Pirotte, Bernard, Kolh, Philippe

    Published in Current medicinal chemistry (01-05-2004)
    “…The pathogenesis of numerous cardiovascular, pulmonary, inflammatory, and thromboembolic diseases can be related to arachidonic acid (AA) metabolites. One of…”
    Get more information
    Journal Article
  15. 15

    From the design to the clinical application of thromboxane modulators by Dogné, Jean-Michel, Hanson, Julien, de Leval, Xavier, Pratico, Domenico, Pace-Asciak, Cecil R, Drion, Pierre, Pirotte, Bernard, Ruan, Ke-He

    Published in Current pharmaceutical design (01-03-2006)
    “…Arachidonic acid (AA) metabolites are key mediators involved in the pathogenesis of numerous cardiovascular, pulmonary, inflammatory, and thromboembolic…”
    Get more information
    Journal Article
  16. 16
  17. 17

    A new potential cyclooxygenase-2 inhibitor, pyridinic analogue of nimesulide by Michaux, Catherine, Charlier, Caroline, Julémont, Fabien, de Leval, Xavier, Dogné, Jean-Michel, Pirotte, Bernard, Durant, François

    Published in European journal of medicinal chemistry (01-12-2005)
    “…In this paper, the binding mode of original pyridinic compounds structurally related to nimesulide, a preferential cyclooxygenase (COX)-2 inhibitor, is…”
    Get full text
    Journal Article Web Resource
  18. 18

    Synthesis, molecular modelling and enzymatic evaluation of (±)3,5-diphenyl-2-thioxoimidazolidin-4-ones as new potential cyclooxygenase inhibitors by Gauthier, Marie P., Michaux, Catherine, Rolin, Stéphanie, Vastersaegher, Caroline, de Leval, Xavier, Julémont, Fabien, Pochet, Lionel, Masereel, Bernard

    Published in Bioorganic & medicinal chemistry (15-02-2006)
    “…Substituted (±)2-thioxoimidazolin-4-ones were synthesized in order to design new type-2 cyclooxygenase (COX-2) inhibitors. Some of them completely inhibit…”
    Get full text
    Journal Article
  19. 19

    Effects of COX-2 inhibitors on ROS produced by Chlamydia pneumoniae-primed human promonocytic cells (THP-1) by Mouithys-Mickalad, Ange, Deby-Dupont, Ginette, Dogne, Jean-Michel, de Leval, Xavier, Kohnen, Stephan, Navet, Rachel, Sluse, Francis, Hoebeke, Maryse, Pirotte, Bernard, Lamy, Maurice

    “…Chronic inflammation through foam cells and macrophages is important in atherosclerosis development, and can be considered as therapeutic targets…”
    Get full text
    Journal Article Web Resource
  20. 20

    Spectral and Crystallographic Study of Pyridinic Analogues of Nimesulide: Determination of the Active Form of Methanesulfonamides as COX-2 Selective Inhibitors by Julémont, Fabien, de Leval, Xavier, Michaux, Catherine, Damas, Jacques, Charlier, Caroline, Durant, François, Pirotte, Bernard, Dogné, Jean-Michel

    Published in Journal of medicinal chemistry (07-11-2002)
    “…Compound 7, N-(3-phenoxy-4-pyridinyl)trifluoromethanesulfonamide, showed in vitro (whole blood assay) a strong inhibitory activity on the two cyclooxygenase…”
    Get full text
    Journal Article Web Resource